Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Aktuální cena Moderna Inc na trhu je 1 337,7 Kč s 24hodinovým objemem obchodování 7,16B Kč. Tržní kapitalizace aktiva je 534,05B Kč po změně o 0.04% za poslední den.
Tokenizovaný Moderna Inc se obchoduje za 1 336,5 Kč, s tokenizovanou tržní kapitalizací 1,15M Kč a 24hodinovým objemem obchodování 40,91K Kč. Tokenizované aktivum se posunulo o 2.80% za posledních 24 hodin.